Related Experiment Video
Updated: Oct 20, 2025
09:36
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
25.7K
Long non-coding RNAs in oncourology
Ilgiz Gareev1, Yulia Gileva1, Aleksandr Dzidzaria2
1Bashkir State Medical University, Ufa, Republic of Bashkortostan, 450008, Russia.
Non-Coding RNA Research
|September 10, 2021
Summary
Long noncoding RNAs (lncRNAs) are crucial in tumor biology, especially in oncourology. Overcoming technical challenges in studying lncRNAs can unlock their potential as biomarkers and therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Genitourinary Cancer Research
Background:
- Tumor biology research traditionally focused on protein-coding genes.
- Non-coding RNAs (ncRNAs), particularly long noncoding RNAs (lncRNAs), are now recognized for their regulatory roles in health and disease.
- lncRNAs play a significant role in the biology of various tumors, including those in the genitourinary system.
Purpose of the Study:
- To highlight the emerging role of lncRNAs in oncourology.
- To discuss the potential of lncRNAs as biomarkers and therapeutic targets in genitourinary tumors.
- To identify challenges hindering the clinical application of lncRNAs in oncourology.
Main Methods:
- Review of current research on lncRNAs in tumor biology.
- Analysis of the application of lncRNAs in oncourology clinical trials.
- Discussion of technological and functional complexities in lncRNA studies.
Main Results:
- lncRNAs are fundamental in the biology of genitourinary tumors.
- Hundreds of clinical trials are investigating lncRNAs as biomarkers and treatments.
- lncRNAs offer potential for improved tumor differentiation, staging, prognosis, and treatment planning.
Conclusions:
- lncRNAs hold promise as innovative biomarkers and therapeutic agents in oncourology.
- Current clinical application is limited by pre-analytical, analytical, and post-analytical challenges.
- Addressing technological hurdles in lncRNA research is key to realizing their clinical potential in oncourology.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K
01:20Types of RNA
7.0K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
7.0K
03:18Non-LTR Retrotransposons
12.2K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.2K
02:18Alternative RNA Splicing
22.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
22.0K
02:53Ribosomal RNA Synthesis
13.7K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
13.7K
01:22MicroRNAs
3.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K